Vosaroxin Completed Phase 2 Trials for Carcinoma, Small Cell / Small Cell Lung Cancer (SCLC) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00298896Safety and Efficacy Clinical Study of SNS-595 in Patients With Advanced Small Cell Lung Cancer